Document is current
Any future updates will be listed below
-
Authors
Zidel, Abbey
Benton, Alex
Brown, Emma
Shmuel, Shayla
Vanover, Alex
Panikar, Sandeep Surendra
Bose, Ron
Park, Haeseong
Davis, Andrew A.
Pereira, Patrícia M. R.
-
Funding
Funding for this research was provided by:
Mallinckrodt Institute of Radiology
National Cancer Center (R37CA276498)
National Cancer Center,United States (R01 CA244233-01A1)
American Cancer Society (IRG-21–133–64–03)
Breast Cancer Alliance
- License Information
-
More Information
Article History
Received: 19 January 2025
Accepted: 9 May 2025
First Online: 15 May 2025
Change Date: 27 June 2025
Change Type: Update
Change Details: The original online version of this Article was revised: The Funding information section was missing from this article and should have read “This research was supported by internal funds provided by the Mallinckrodt Institute of Radiology, NIH (R37CA276498 and R01 CA244233-01A1, P.M.R. Pereira), in part by the American Cancer Society (IRG-21–133–64–03, P.M.R. Pereira), and the Breast Cancer Alliance (P.M.R. Pereira).”
Declarations
:
: AAD participates in Scientific Advisory Boards for Pfizer and Biotheranostics (unrelated to the studies that are described here). The other authors declare no potential conflicts of interest.
: PMRP reports grants from the NIH, Breast Cancer Alliance, the Siteman Cancer Center, and The Elsa Pardee Foundation during the conduct of the study. AAD reports a grant from the Breast Cancer Alliance. No disclosures were reported by the other authors.
